Table 1.
Galectin-9 and its binding partners in the regulation of immune response and tumor biology.
| Ligand | Targeted cells | Biological function | Refs. |
|---|---|---|---|
| Tim-3 | Dendritic cells, monocytes | Maturation promotion and cytokine secretion | 36,38 |
| Tim-3 | T cells | Exhaustion or apoptosis | 32,39 |
| Tim-3 | Natural killer cells | Regulating cell function at the maternal–fetal interface in early pregnancy | 40 |
| PD-1 | T cells | Suppressing Gal-9/TIM-3-induced T cell apoptosis | 41 |
| Dectin-1 | Macrophages | Tolerogenic macrophage programming and adaptive immune suppression | 42 |
| CD206 | Macrophages | Driving angiogenesis and producing chemokines to support tumor growth | 43 |
| CD40 | T cells | Suppressing proliferation and inducing cell death | 44 |
| 4-1BB | T cells | Transducing signal and controlling functional activity | 45 |
| VISTA | T cells | Apoptosis | 46 |
| DR3 | Regulatory T cells | Facilitating the activity of DR3 with respect to promoting Treg function that limits inflammatory disease | 47 |
| CD44 | Regulatory T cells | Increasing cell stability and function, and enforcing cell differentiation and maintenance | 48 |
| TLR-4 | Microglia | Alleviating brain injury and promoting neuronal restoration | 49 |
Abbreviations: PD-1, programmed cell death protein 1; VISTA, V-domain Ig-containing suppressor of T cell activation; TLR-4, Toll-like receptor-4